Nomura Downgrades Unisplendour to Neutral From Buy, Adjusts Price Target to 22.50 Yuan From 25 Yuan
Nomura Adjusts Hangzhou Tigermed Consulting's Price Target to HK$30.65 From HK$32.69, Keeps at Neutral
Nomura Adjusts WuXi AppTec's Price Target to HK$43.45 From HK$54.56, Keeps at Buy
Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 48.32 Yuan From 51.12 Yuan, Keeps at Neutral
Nomura Adjusts Shanghai United Imaging Healthcare's Price Target to 122.36 Yuan From 139.25 Yuan, Keeps at Neutral
Nomura Adjusts Shenzhen New Industries Biomedical Engineering's Price Target to 95.86 Yuan From 93.36 Yuan, Keeps at Buy
Nomura Adjusts Shenzhen Mindray Bio-Medical Electronics' Price Target to 425.97 Yuan From 422.45 Yuan, Keeps at Buy
Citi Sticks to Their Buy Rating for Zhuzhou CRRC Times Electric Co (ZHUZF)
Nomura Adjusts Aier Eye Hospital's Price Target to 13.70 Yuan From 15.35 Yuan, Keeps at Buy
Jefferies Remains a Buy on BYD Co (BYDDF)
Jefferies Adjusts BYD's Price Target to 317 Yuan From 284 Yuan, Keeps at Buy
Goldman Sachs Downgrades Yonyou Network Technology to Neutral From Buy; Price Target Is 10.13 Yuan
Buy Rating Affirmed for Great Wall Motor Co. With Growth and Profitability in Focus
Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to 107.91 Yuan From 118.48 Yuan, Keeps at Buy
Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to HK$76.45 From HK$83.94, Keeps at Buy
Nomura Adjusts China Vanke's Price Target to 4.70 Yuan From 5.10 Yuan, Keeps at Reduce
China Renaissance Downgrades East Money Information to Hold From Buy, Price Target Is 10.20 Yuan
Morgan Stanley Downgrades Aier Eye Hospital to Underweight From Equal-weight; Price Target Is 9.80 Yuan
Morgan Stanley Adjusts Maxscend Microelectronics Company's Price Target to 66 Yuan From 85 Yuan, Keeps at Underweight
Nomura Downgrades Zhejiang Sanhua Intelligent Controls to Neutral From Buy, Adjusts Price Target to 20 Yuan From 36 Yuan